(1 - 9 from 11
)
Frank Accurso Joins NetRead as Vice President of Customer ...www.netread.com › netread › press
netread.com
Frank Accurso Joins NetRead as Vice President of Customer Applications. (San Francisco, CA - August 29, 2000) - NetRead, a web-based marketing ...
Cystic Fibrosis and the New Millennium clinical
www.cfmedicine.com
Dr Frank Accurso (figure 6) is Professor of Pediatrics and Head of Pulmonary Medicine at the University of Colorado. Following the selection of the …
Villingen-Schwenningen: Ein Arbeitsleben bei der Stadt -...
www.schwarzwaelder-bote.de
Oberbürgermeister ehrt langjährig Beschäftigte
Accurso retires after 42 years in medicine at CU | University of ...www.cu.edu › news › accurso-retires-after-42-years-me...
www.cu.edu
As a newly minted physician in 1974, Dr. Frank Accurso accepted a pediatric residency at the University of Colorado Health Sciences Center and later chose the ...
Biomarkers for Cystic Fibrosis Drug Development | European Cystic...
www.ecfs.eu
Marianne S. Muhlebach. JP Clancy. Sonya L. Heltshe. Assem Ziady. Tom Kelley. Frank Accurso. Joseph Pilewski. Nicole Mayer-Hamblett. Elizabeth Joseloff.
Drug Targets Faulty Process That Drives Cystic Fibrosis
consumer.healthday.com
This medicine might help minority of patients with particular gene, but others like it could follow
Open Channels | The New Yorker
www.newyorker.com
Do new cystic-fibrosis therapies hold the key to treating other genetic disorders?
Untitled Document - GenomeWebwww.genomeweb.com › newspics › Proteo_NIH_
crain-platform-genomeweb-prod.s3.amazonaws.com
Frank Accurso, Clinical proteomics center in lung disease, University of Colorado, Denver/ Health Science, Aurora. Aug. 15, June 30, $1,001,028.
New Cystic Fibrosis Drug Improves Lung Function
www.webmd.com
''These findings are encouraging," researcher Frank Accurso, MD, professor of pediatrics at the University of Colorado School of Medicine, Denver, tells WebMD. The drug is called denufosol. ''The patients who received the ...
sorted by relevance / date